1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P99143
    Anti-Mouse NK1.1 Antibody (PK136) Inhibitor
    Anti-Mouse NK1.1 Antibody (PK136) 是一种抗小鼠 NK1.1 IgG2a 单克隆抗体。Anti-Mouse NK1.1 Antibody (PK136) 可以耗竭自然杀伤 (NK) 细胞。Anti-Mouse NK1.1 Antibody (PK136) 抑制 JAK-STATNF-κB 信号通路。Anti-Mouse NK1.1 Antibody (PK136) 可用于研究炎症疾病,如非酒精性脂肪性肝炎 (NASH)。
    Anti-Mouse NK1.1 Antibody (PK136)
  • HY-N0440
    Germacrone Inhibitor 99.76%
    Germacrone 是一种具有多种生物活性的倍半萜化合物。Germacrone 可抑制 H1N1 和 H3N2 甲型流感病毒以及乙型流感病毒。Germacrone 通过调节 Th1/Th2 平衡和抑制 NF-κB 信号传导来阻止关节炎的进展。Germacrone 可将细胞周期停滞在 G0/G1 和 G2/M 期,并诱导乳腺癌细胞凋亡 (apoptosis)。Germacrone 抑制 5α-还原酶 (5α-reductase) 并具有抗雄激素作用。Germacrone 具有神经保护功能,可用于创伤性脑损伤 (TBI) 的研究。Germacrone 还具有抗氧化活性。
    Germacrone
  • HY-124179
    IT-901 Inhibitor 99.32%
    IT-901 是一种具有口服活性且有效的 NF-κB 亚基 c-Rel 抑制剂,对 NF-κBc-Rel 与 DNA 结合的 IC50 分别为 0.1 μM,3 μM。IT-901 是一种具有生物活性的萘硫代巴比妥酸酯衍生物,具有用于人类淋巴瘤和改善移植物抗宿主病 (GVHD) 的潜力。
    IT-901
  • HY-10072
    SPC 839 Inhibitor 99.86%
    SPC 839 (compound 10) 是一种具有口服活性的 AP-1NF-kB 介导的转录激活抑制剂,其 IC50 值为 0.008 μM。
    SPC 839
  • HY-N0253
    Hederacoside C

    常春藤苷C

    Inhibitor 99.85%
    Hederacoside C (Kalopanaxsaponin B) 是一种可从常春藤叶子中主得到的成分。Hederacoside C 通过抑制 MAPK/NF-κB 及其下游信号通路的激活介导炎症反应。Hederacoside C 具有抗炎和抗菌 (antibacterial) 活性。
    Hederacoside C
  • HY-126382
    Hesperidin methylchalcone Inhibitor 98.0%
    Hesperidinmethylchalcone (Hesperidinmethylchalcone) 是一种口服活性黄酮类化合物,具有镇痛、抗炎和抗氧化特性。Hesperidin methylchalcone 具有血管保护活性。Hesperidin methylchalcone 抑制氧化应激、细胞因子产生和 NF-κB 激活。Hesperidin methylchalcone 可用于痛风疾病的研究。
    Hesperidin methylchalcone
  • HY-107802
    Breviscapine

    灯盏花素

    Inhibitor
    Breviscapine 是灯盏花的黄酮类粗提取物,85% 以上为有效成分,灯盏花乙素。Breviscapine 具有广泛的心血管药理活性,如增加血流量、改善微循环、扩张血管、降低血液粘度、促进纤溶、抑制血小板聚集、血栓形成等。Breviscapine 已用于脑梗塞及其后遗症、脑血栓、冠心病、心绞痛的研究中发挥出优良效力。
    Breviscapine
  • HY-N9914
    D-Psicose

    D-阿洛酮糖

    Inhibitor 99.89%
    D-psicose 是一种口服活性稀有糖。D-psicose 抑制 p38-MAPK 磷酸化、MCP-1 表达。D-psicose 抑制 AGEs/RAGE/NF-κB 通路。D-psicose 保护胰腺 β 胰岛、改善高血糖症和高脂饮食诱导的非酒精性脂肪肝。
    D-Psicose
  • HY-14592
    Tectochrysin

    柚木柯因

    Inhibitor 99.88%
    Tectochrysin (Techtochrysin) 是 Alpinia oxyphylla 的主要黄酮类化合物之一。 Tectochrysin 抑制 NF-κB 活性。
    Tectochrysin
  • HY-N2056
    11-​Keto-​beta-​boswellic acid

    11-酮-β-乳香酸

    Inhibitor 99.96%
    11-Keto-beta-boswellic acid (11-Keto-β-boswellic acid) 是一种五环三萜酸,来自俗称印度乳香 (Indian Frankincense) 的乳香树 (Boswellia serrate) 树皮的油树脂。 11-Keto-beta-boswellic acid 具有抗炎活性,主要是由于抑制 5-脂氧合酶 (5-lipoxygenase; 5-LOX)白三烯 (leukotriene)NF-κB的激活和肿瘤坏死因子 α 的产生。
    11-​Keto-​beta-​boswellic acid
  • HY-107818
    4-Hydroxychalcone Inhibitor 99.29%
    4-Hydroxychalcone 是查尔酮代谢物,具有抗血管生成和消炎作用。 4-Hydroxychalcone 通过抑制生长因子途径抑制血管生成,无细胞毒性迹象。4-Hydroxychalcone 抑制 TNF-α 诱导的 NF-κB 途径活化并激活 BMP 信号传导,通过减轻小鼠的醛固酮过多症和肾脏损伤来降低抵抗性高血压 (RH)。
    4-Hydroxychalcone
  • HY-N0841
    Bruceine A

    鸦胆子素A

    Inhibitor 99.89%
    Bruceine A (Dihydrobrusatol) 是一种天然的苦木素。Bruceine A 是一种寄生虫 (parasites),NF-κB,和 PFKFB4 (Kd: 44 nM) 抑制剂。Bruceine A 是一种 P38α MAPK 激活剂。Bruceine A 具有抗寄生虫活性。Bruceine A 具有抗肿瘤活性并抑制癌细胞迁移。Bruceine A 可阻断细胞周期并诱导细胞凋亡 (apoptosis)。Bruceine A 可用于寄生虫、胰腺癌和乳腺癌的研究。
    Bruceine A
  • HY-18325
    AN-3485 Inhibitor
    AN-3485 是一种 benzoxaborole 类似物和口服有效的 Toll 样途径拮抗剂。AN-3485 能够抑制 TLR 介导的炎症细胞因子分泌,具有显著的抗炎活性。此外,AN-3485 还具有一定的抗肿瘤活性。
    AN-3485
  • HY-B0900
    Anethole

    茴香脑

    Inhibitor 99.81%
    Anethole 是一类具有口服活性的芳香族化合物,用作调味剂,广泛存在于自然界中。Anethole 具有抗癌、抗炎、抗氧化、抗菌、抗真菌、麻醉、雌激素、中枢神经系统抑制、催眠、杀虫剂、和胃保护作用。Anethole 可以用于氧化应激相关皮肤病、前列腺癌的研究 。
    Anethole
  • HY-N1363
    Royal Jelly acid

    王浆酸

    Inhibitor 99.95%
    Royal Jelly acid ((E)-Queen Bee Acid) 是一种可在蜂王浆中被发现的主要的脂肪酸,具有口服活性,具有抗炎、抗癌、抗疟疾、抗原虫以及神经调节多种活性。Royal Jelly acid 可用于癌症、感染、免疫炎症、神经疾病等多领域研究。
    Royal Jelly acid
  • HY-N0602
    Ginsenoside Rg2

    人参皂苷 Rg2

    Inhibitor 98.11%
    Ginsenoside Rg2 是人参的主要活性成分之一。Ginsenoside Rg2抑制脂多糖介导的 VCAM-1ICAM-1 表达的增加。 Ginsenoside Rg2 还降低 1-42 积聚。
    Ginsenoside Rg2
  • HY-N0563
    Alizarin

    茜素

    Inhibitor 99.48%
    Alizarin 是一种天然染料。Alizarin 可从茜草植物根部提取。Alizarin 激活 AMPKVEGFR2/eNOS 通路。Alizarin 调节 PI3K/Akt 并抑制 >NF-κB 通路。Alizarin 增强 CYP1A1 酶活性。Alizarin 对高血压和血管内皮功能障碍有保护作用。Alizarin 对多种癌症具有抗肿瘤活性,包括胰腺癌、乳腺癌、骨肉瘤和肝癌。Alizarin 已广泛用作纺织品和绘画中的颜料。
    Alizarin
  • HY-N1193
    Sulfuretin

    硫黄菊素

    Inhibitor 99.36%
    Sulfuretin 通过抑制 NF-κB 通路来抑制炎症反应。 Sulfuretin 可用于过敏性气道炎症的研究。Sulfuretin 减少氧化应激、血小板聚集和诱变。Sulfuretin 是一种竞争性的有效单酚酶和二酚酶活性抑制剂,IC50 为 13.64 μM。
    Sulfuretin
  • HY-19696B
    Tauroursodeoxycholate dihydrate

    牛磺熊去氧胆酸二水合物

    Inhibitor 99.96%
    Tauroursodeoxycholate dehydrate 是口服活性的 Ursodeoxycholic acid (HY-13771) 牛磺酸共轭物。Tauroursodeoxycholate dehydrate 抑制 caspase-3/7、凋亡 (Apoptosis)、IRE1α/TRAF2/NF-κB,预防 JNK 磷酸化,抑制 ROS 生成,激活 Akt 信号传导。Tauroursodeoxycholate dehydrate 预防白内障形成、减轻 2 型糖尿病小鼠中的肾小管损伤、减轻肝脏 I/R 损伤、抑制非酒精性脂肪肝中肠道炎症和屏障破坏。
    Tauroursodeoxycholate dihydrate
  • HY-N0267
    Hypaconitine

    次乌头碱

    Inhibitor 99.49%
    Hypaconitine 抑制 KCNH2 电流,IC50 为 8.1 nM,并表现出心脏毒性。Hypaconitine 通过抑制 NF-κB 核转位来抑制 TGF-β1 诱导的 A549 细胞上皮间质转化(EMT)。Hypaconitine 可以用作神经肌肉阻滞剂。Hypaconitine 具有口服活性。
    Hypaconitine
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.